deltatrials
Completed PHASE4 INTERVENTIONAL 1-arm NCT01938378

Octaplas Pediatric Plasma Exchange Trial (Octaplas)

An Open-label, Multicenter, Post-Marketing Requirement Study to Investigate the Safety and Tolerability of Octaplas™ in the Management of Pediatric Patients Who Require Therapeutic Plasma Exchange

Sponsor: Octapharma

Conditions Adverse Effects in the Therapeutic Use of Plasma Substitutes
Interventions Octaplas™
Updated 13 times since 2017 Last updated: Mar 23, 2020 Started: Apr 30, 2015 Primary completion: Jan 27, 2019 Completion: Jan 27, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Adverse Effects in the Therapeutic Use of Plasma Substitutes and is currently completed. Octapharma leads this study, which shows 13 recorded versions since 2015 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Aug 2017 · 6 months · monthly snapshot~Aug 2017 – ~Jun 2018 · 10 months · monthly snapshot~Jun 2018 – ~Feb 2019 · 8 months · monthly snapshot~Feb 2019 – ~Nov 2019 · 9 months · monthly snapshot~Nov 2019 – ~Apr 2020 · 5 months · monthly snapshot~Apr 2020 – ~Jan 2021 · 9 months · monthly snapshot~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

13 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  4. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE4

  5. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE4

▶ Show 8 earlier versions

  1. Jan 2021 — Dec 2022 [monthly]

    Completed PHASE4

  2. Apr 2020 — Jan 2021 [monthly]

    Completed PHASE4

  3. Nov 2019 — Apr 2020 [monthly]

    Completed PHASE4

    Status: Recruiting → Completed

  4. Feb 2019 — Nov 2019 [monthly]

    Recruiting PHASE4

  5. Jun 2018 — Feb 2019 [monthly]

    Recruiting PHASE4

  6. Aug 2017 — Jun 2018 [monthly]

    Recruiting PHASE4

  7. Feb 2017 — Aug 2017 [monthly]

    Recruiting PHASE4

  8. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE4

    First recorded

Apr 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Octapharma
Data source: Octapharma

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations